浙江医药 (600216.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(浙江医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 7,112,804,346.304,405,467,286.372,249,164,467.207,794,145,971.375,876,518,447.273,937,942,897.552,007,935,140.53
 营业利润(元) 937,076,246.21341,433,350.41101,797,810.27380,158,265.10259,254,227.97252,816,649.35105,302,495.52
 利润总额(元) 930,805,265.38334,589,302.43101,044,464.45363,278,706.95268,382,586.93262,915,098.18102,362,847.29
 净利润(元) 758,558,082.68255,365,468.0179,363,327.86276,794,127.84180,865,708.32187,000,510.5684,072,216.08
 归属于母公司股东的净利润(元) 849,651,818.01315,332,017.87109,649,638.31429,639,626.26301,338,595.24272,261,125.88113,551,849.15
盈利能力:
 销售毛利率(%) 40.0535.3932.9232.3933.5733.8433.75
 销售净利率(%) 10.665.803.533.553.084.754.19
 净资产收益率(%) 8.563.221.15----
 总资产报酬率ROA(%) 7.132.550.81----
 投入资本回报率ROIC(%) 7.882.971.044.182.952.651.12
营运能力:
 存货周转率(次) 2.191.430.79----
 应收账款周转率(次) 4.733.301.56----
 总资产周转率(次) 0.550.340.18----
偿债能力:
 资产负债率(%) 21.0020.4522.0221.8621.3920.8421.31
 股东权益比率(%) 77.0077.2475.4475.3675.5575.8675.31
 已获利息倍数(倍) -323.38-41.1351.35-19.77-11.97-6.869.94
 流动比率 2.612.662.382.262.142.282.26
 速动比率 1.721.711.571.411.331.421.41
发展能力:
 营业收入增长率(%) 21.0411.8712.01-3.96-4.04-4.36-8.07
 营业利润增长率(%) 261.4535.05-3.33-24.66-48.31-39.54-60.71
 税后利润增长率(%) 181.9615.82-3.44-20.37-37.80-30.29-56.42
 净资产增长率(%) 8.703.083.594.003.808.803.97
 总资产增长率(%) 6.641.243.422.791.793.16-0.70

前瞻产业研究院